Experimental models of dermal fibrosis and systemic sclerosis

被引:13
|
作者
Avouac, Jerome [1 ]
Elhai, Muriel [1 ]
Allanore, Yannick [1 ]
机构
[1] Paris Descartes Univ, Cochin Hosp, Rheumatol Dept A, INSERM,U1016,CNRS,UMR8104,Cochin Inst, Paris, France
关键词
Systemic sclerosis; Animal models; Dermal fibrosis; VERSUS-HOST-DISEASE; MAST-CELL DEPLETION; LUNG FIBROSIS; MURINE MODEL; T-CELLS; SCLERODERMA; SKIN; DNA; ACTIVATION; RECEPTOR;
D O I
10.1016/j.jbspin.2012.06.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Vasculopathy, immunological abnormalities, and fibrosis are the key features in the pathogenesis of systemic sclerosis (SSc). Expression of each of the three pathologic features varies among SSc patients leading to disease heterogeneity and variable organ manifestations. Although the etiology of SSc has not yet been fully elucidated, a growing body of evidence suggests that extracellular matrix overproduction by activated fibroblasts results from a complex interplay between endothelial cells, immune cells and fibroblasts through cell cell and cell matrix interactions and communications. Relevant animal models are essential tools to in-depth investigate pathogenesis of SSc. Several murine and avian models are available; however, some models display inflammation followed by fibrosis, whether some others primarily mimic autonomous fibroblast activation. In addition, typical microvascular changes of SSc are only observed in few models. Therefore, none of these animal models encompasses all features of the human disease and a critical selection is mandatory for successful in vivo studies. Hence, we will provide an overview of the most important experimental models of dermal fibrosis and SSc and discuss their respective contribution to the better understanding of SSc pathogenesis. (c) 2012 Societe francaise de rhumatologie. Published by Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:23 / 28
页数:6
相关论文
共 50 条
  • [31] Epigenetic activation of a novel TGFβ2 enhancer sustains dermal fibrosis in systemic sclerosis
    Shin, J. Y.
    Beckett, J.
    Dietz, H. C.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (05) : S75 - S75
  • [32] THE DERMAL MICROVASCULATURE IN SYSTEMIC-SCLEROSIS
    FREEMONT, AJ
    FIELDING, P
    JAYSON, MIV
    JONES, CJP
    BRITISH JOURNAL OF RHEUMATOLOGY, 1985, 24 (02): : 211 - 212
  • [33] Attenuation of fibrosis with selective inhibition of c-Abl by siRNA in systemic sclerosis dermal fibroblasts
    Karimizadeh, Elham
    Motamed, Nasrin
    Mahmoudi, Mahdi
    Jafarinejad-Farsangi, Saeideh
    Jamshidi, Ahmadreza
    Faridani, Habibeh
    Gharibdoost, Farhad
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2015, 307 (02) : 135 - 142
  • [34] Fasudil ameliorates fibrosis and immune abnormalities in animal models of systemic sclerosis
    Toyama, T.
    Asano, Y.
    Sato, S.
    Sugaya, M.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (05) : S184 - S184
  • [35] A potential contribution of altered cathepsin L expression to the development of dermal fibrosis and vasculopathy in systemic sclerosis
    Yamashita, Takashi
    Asano, Yoshihide
    Taniguchi, Takashi
    Nakamura, Kouki
    Saigusa, Ryosuke
    Takahashi, Takehiro
    Ichimura, Yohei
    Toyama, Tetsuo
    Yoshizaki, Ayumi
    Miyagaki, Tomomitsu
    Sugaya, Makoto
    Sato, Shinichi
    EXPERIMENTAL DERMATOLOGY, 2016, 25 (04) : 287 - 292
  • [36] Serum vasohibin-1 levels: A potential marker of dermal and pulmonary fibrosis in systemic sclerosis
    Fukui, Yuki
    Nakamura, Kouki
    Hirabayashi, Megumi
    Miyagawa, Takuya
    Toyama, Satoshi
    Omatsu, Jun
    Awaji, Kentaro
    Ikawa, Tetsuya
    Norimatsu, Yuta
    Yoshizaki, Ayumi
    Sato, Shinichi
    Asano, Yoshihide
    EXPERIMENTAL DERMATOLOGY, 2021, 30 (07) : 951 - 958
  • [37] Attenuation of fibrosis with selective inhibition of c-Abl by siRNA in systemic sclerosis dermal fibroblasts
    Elham Karimizadeh
    Nasrin Motamed
    Mahdi Mahmoudi
    Saeideh Jafarinejad-Farsangi
    Ahmadreza Jamshidi
    Habibeh Faridani
    Farhad Gharibdoost
    Archives of Dermatological Research, 2015, 307 : 135 - 142
  • [38] Glycyrrhizin Ameliorates Fibrosis, Vasculopathy, and Inflammation in Animal Models of Systemic Sclerosis
    Yamashita, Takashi
    Asano, Yoshihide
    Taniguchi, Takashi
    Nakamura, Kouki
    Saigusa, Ryosuke
    Miura, Shunsuke
    Toyama, Tetsuo
    Takahashi, Takehiro
    Ichimura, Yohei
    Yoshizaki, Ayumi
    Trojanowska, Maria
    Sato, Shinichi
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017, 137 (03) : 631 - 640
  • [39] INHIBITION OF AUTOPHAGY PREVENTS PROGRESSION OF FIBROSIS IN MURINE MODELS OF SYSTEMIC SCLEROSIS
    Zehender, A.
    Li, Y. N.
    Lin, N. Y.
    Gyoerfi, A. H.
    Soare, A.
    Bergmann, C.
    Ramming, A.
    Schett, G.
    Distler, J. H. W.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1075 - 1075
  • [40] INTRAVENOUS IMMUNOGLOBULINS PREVENTS EXPERIMENTAL FIBROSIS IN A MURINE MODEL OF SYSTEMIC SCLEROSIS
    Farhat, M. -M.
    Speca, S.
    Jendoubi, M.
    Hauspie, C.
    Guerrier, T.
    Sobanski, V.
    Sanges, S.
    Hachulla, E.
    Lefevre, G.
    Labalette, M.
    Dubucquoi, S.
    Launay, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 740 - 740